Skip to main content

Additional Articles by the Author

Select Drug Profiles, Payers' Guide

Yescarta (Axicabtagene Ciloleucel) Second CAR T-Cell Therapy Approved for Patients with Certain Types of Large B-Cell Lymphoma

Select Drug Profiles, Payers' Guide

Xeljanz/Xeljanz XR (Tofacitinib/Tofacitinib XR), an Oral JAK Inhibitor, Now Approved for Adults with Active Psoriatic Arthritis

Select Drug Profiles, Payers' Guide

Xadago (Safinamide), an Oral MAO-B Inhibitor, FDA Approved as Adjunctive Treatment for Patients with Parkinson’s Disease

Select Drug Profiles, Payers' Guide

Verzenio (Abemaciclib) a New CDK4/CDK6 Inhibitor Approved for HR-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Select Drug Profiles, Payers' Guide

Kymriah (Tisagenlecleucel) for Young Patients with Acute Lymphoblastic Leukemia: First FDA-Approved Gene Therapy

Select Drug Profiles, Payers' Guide

Kevzara (Sarilumab), a New IL-6 Receptor Antagonist, Approved for Active Rheumatoid Arthritis

Select Drug Profiles, Payers' Guide

Gazyva (Obinutuzumab) Approved for Patients with Rituximab-Refractory Follicular Lymphoma

Select Drug Profiles, Payers' Guide

Lartruvo (Olaratumab) a Novel First-Line Treatment Approved for Patients with Advanced Soft-Tissue Sarcoma

Select Drug Profiles, Payers' Guide

Soliqua 100/33 (Insulin Glargine plus Lixisenatide) Receives FDA Approval for Adults with Type 2 Diabetes

Yondelis (Trabectedin) Approved for the Treatment of Unresectable or Metastatic Soft-Tissue Sarcomas

1
2
3
4
5
6
7

Page 4 of 10
Results 31 - 40 of 98